Johnson & Johnson's COVID-19 vaccine trial paused over unexplained illness
A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s "unexplained illness” is related to the shot. The company said in a statement Monday evening that illnesses, accidents and other so-called adverse events "are ...
Johnson & Johnson’s vaccine advances, sparking optimism in race
The company's vaccine could require just one shot instead of two — important considering that the entire population of the world needs vaccination.
Japan in talks with Johnson & Johnson to secure COVID-19 vaccine
The company has already agreed to prioritize an allocation to the United States as part of a funding agreement, according to the firm's chief financial officer.
Firms sign deals with U.S. to prep for mass-producing virus vaccines
The U.S. government has cut deals with Johnson & Johnson and Moderna Inc. and said it is in talks with at least two other companies to prepare them to produce massive quantities of coronavirus vaccines even before safe and effective ones become available. There are ...
U.S. developing vaccine against deadly China virus and urges Beijing cooperation
The United States said Tuesday it was developing a vaccine against a deadly virus that originated in China, and urged Beijing to step up its cooperation with international health authorities. The U.S. government is keen to place its own teams on the ground to review ...
J&J CEO says he didn't read internal documents on possible asbestos in Baby Powder
Johnson & Johnson Chief Executive Alex Gorsky told a jury Monday that he did not read all the internal company documents related to potential asbestos contamination in Johnson's Baby Powder. It was the CEO's first appearance in a jury trial over allegations that the company's ...
Largest study yet offers no clear talc link to ovarian cancer
U.S. researchers who conducted the largest study yet into whether applying powder to the genitals increases a woman's risk of ovarian cancer were unable to definitively put to rest the issue that has prompted thousands of lawsuits against Johnson & Johnson and other companies. Overall, ...
Rwanda begins vaccinating against Ebola at border with Congo
Rwanda on Sunday started a voluntary Ebola vaccination program at its border with the Democratic Republic of Congo in a bid to prevent the spread of the deadly virus from its neighbor. All countries in high-risk areas, even if not hit by Ebola, had been ...
While some Johnson & Johnson investors were relieved that the company's $572 million penalty for fueling Oklahoma's opioid epidemic wasn't as high as feared, lawyers for other U.S. states, cities and counties could hardly contain their glee. That's because the ruling by Oklahoma Judge Thad ...
Congo health minister's resignation over Ebola snub could unblock new vaccine
Congo's health minister resigned on Monday after being stripped of responsibility for managing the country's Ebola outbreak, potentially paving the way for the introduction of a second vaccine to contain the spreading epidemic. Oly Ilunga has overseen Congo's near year-long response to what is the ...
U.S. giant Johnson & Johnson makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z
U.S. health care conglomerate Johnson & Johnson said on Tuesday it will buy all outstanding shares of Japanese skin care firm Ci:z Holdings Co. that it does not already own for ¥230 billion ($2.05 billion) in cash. J&J is betting the deal — which will ...
A Missouri jury on Thursday ordered Johnson & Johnson to pay a record $4.69 billion to 22 women who alleged the company's talc-based products, including its baby powder, contain asbestos and caused them to develop ovarian cancer. The verdict is the largest the firm has ...
